Tripep AB (publ.)—Year-end Report—July - December 2006 Corporate identity number: 556705-1965
• The company had no net sales for the period July – December 2006.• Research and development costs for the period July – December 2006 amounted to SEK 13.3 million.• The loss after tax for the period July - December 2006 was SEK -21.1 million.• Earnings per share for the period July - December 2006 were SEK -0.78.• In December, Tripep filed an application with the Swedish Medical Products Agency to approve the start of a phase I trial on Tripep’s ChronVac-C®.• In October, Tripep AB acquired a project, ChronSeal, for treating chronic wounds developed by researchers at Linköping